Výsledky vyhledávání - "Eugenia Pedagogos"

Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3-4 CKD - results from a placebo-controlled randomised trial

Autor: Mark K Tiong, Edward R Smith, Elaine M Pascoe, Grahame J Elder, Nicole M Lioufas, Eugenia Pedagogos, Carmel M Hawley, Andrea Valks, Stephen G Holt, Tim D Hewitson, Nigel D Toussaint

Publikováno v: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Background Calciprotein particles (CPP) are colloidal aggregates of calcium phosphate and the mineral-binding protein fetuin-A, and are potential mediators of cardiovascular disease in chronic kidney disease (CKD). Emerging evidence suggests non-calc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb9bf9e3de1b4fbc54f9ff924aaa228
https://pubmed.ncbi.nlm.nih.gov/35212735

Zobrazit plný text záznamu

The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis

Autor: Nigel D Toussaint, Grahame J Elder, Irene Ruderman, Eugenia Pedagogos, Carmel M. Hawley, Nicole Lioufas, Rathika Krishnasamy

Publikováno v: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 36(4)

Background Calciphylaxis is a rare disease, predominantly affecting patients with chronic kidney disease (CKD) and associated with significant morbidity and mortality due to progressive cutaneous calcification, necrotic ulceration and infection. Clin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fc669ead90d1ff3616202ffacc59c41
https://pubmed.ncbi.nlm.nih.gov/31855262

Zobrazit plný text záznamu

Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

Autor: Elaine M. Pascoe, Sunil V. Badve, Eugenia Pedagogos, Carmel M. Hawley, Andrea Valks, Grahame J Elder, Nicole Lioufas, Nigel D Toussaint

Publikováno v: BMJ Open

IntroductionPatients with chronic kidney disease (CKD) are at heightened cardiovascular risk, which has been associated with abnormalities of bone and mineral metabolism. A deeper understanding of these abnormalities should facilitate improved treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a36d3e62cbac7df2301288b35ff7350
https://doi.org/10.1136/bmjopen-2018-024382

Zobrazit plný text záznamu

Bradycardia and Asystole Is the Predominant Mechanism of Sudden Cardiac Death in Patients With Chronic Kidney Disease

Autor: Jonathan M. Kalman, Peter M. Kistler, Paul B. Sparks, S. Joseph, Michael C.G. Wong, Geoffrey Lee, Karen Halloran, Prashanthan Sanders, Eugenia Pedagogos, Nigel D Toussaint, Jitendra K. Vohra, Joseph B. Morton

Publikováno v: Journal of the American College of Cardiology. 65(12):1263-1265

Patients with chronic kidney disease (CKD) undergoing hemodialysis experience a high annual mortality rate (7% per year) with 25% of all deaths due to sudden cardiac death (SCD) [(1)][1]. There has been conjecture as to the mechanism of SCD. This pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca8c43b53e751a5ca84c6bb912b18309

Zobrazit plný text záznamu

Temporal distribution of arrhythmic events in chronic kidney disease: Highest incidence in the long interdialytic period

Autor: Michael C.G. Wong, Peter M. Kistler, Jonathan M. Kalman, Eugenia Pedagogos, Nigel D Toussaint, Karen Halloran, Prashanthan Sanders, Paul B. Sparks, Geoffrey Lee, S. Joseph, Jitendra K. Vohra, Joseph B. Morton

Publikováno v: Heart rhythm. 12(10)

Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) have a high risk of sudden cardiac death (SCD). A unique risk factor may be a longer interval between HD sessions (interdialytic period). Inherent in conventional HD (thrice-weekly) a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a653081b4e7c49fb3d6c3278e6176cf
https://pubmed.ncbi.nlm.nih.gov/26188252

Zobrazit plný text záznamu

Double-Blind, Placebo-Controlled Study on the Effect of the Aldosterone Receptor Antagonist Spironolactone in Patients Who Have Persistent Proteinuria and Are on Long-Term Angiotensin-Converting Enzyme Inhibitor Therapy, with or without an Angiotensin II Receptor Blocker

Autor: Gavin J. Becker, Lachlan MacGregor, Anastasia Chrysostomou, Eugenia Pedagogos

Publikováno v: Clinical Journal of the American Society of Nephrology. 1:256-262

Studies have shown that dual therapy with angiotensin-converting enzyme inhibitors (ACEI) and either angiotensin II receptor blockers or aldosterone receptor antagonists is more effective in reducing proteinuria than either agent used alone. The ques

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5940d8f986aa6d0387a7751cb1afc4fe
https://doi.org/10.2215/cjn.01040905

Zobrazit plný text záznamu

Hyaluronan and Rat Renal Fibroblasts: In vitro Studies

Autor: Tim D. Hewitson, Eugenia Pedagogos, Gavin J. Becker, Kathleen M. Nicholls

Publikováno v: Nephron. 88:347-353

Hyaluronic acid (HA) is a ubiquitous component of extracellular matrix. After tissue injury, HA appears in greater abundance during the inflammatory response and the phase of clearance of cell and matrix debris, before collagen production and matrix

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c5327b5b6febbc3571c72430184029
https://doi.org/10.1159/000046019

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání